Skin Implant Could Spell the End of Malignant Melanoma

Researchers at Harvard University who put forward a remarkable new treatment for skin cancer for clinical trials are now eagerly awaiting the results.  The novel new technique involves using a tiny implant the size of a fingernail.  The implant is placed beneath the patient’s skin and ‘instructs’ the body’s immune cells to target and kill cancer cells.  This innovative new technology is just one of several revolutionary alternative cancer vaccine treatments under development.


The implant was first trialed by scientists in mice a number of years ago and the technique was now been perfected and approved for human trials in 2013.  The implant targets melanoma – the most serious and deadly form of skin cancer.  In their initial experiments researchers observed that half the mice used that were given two doses of vaccine demonstrated total regression of their cancer tumors.

The clever implant technology works like ordinary vaccines in that it helps the body’s immune system to identify and target early cancer cells.  The research into this and other forms of cancer vaccines is still in its infancy, but it is hoped that many viable future treatments will emerge.  The Harvard device could in fact herald the dawn of a new era in cancer treatment.

Phase 1 study results awaited

The Phase 1 human study which is intended to determine if the implant device is actually safe for clinical use should be completed later this year.  Even if approval is gained and the trial is a success, it could be many years before the treatment is widely available to patients.  Larger scale trials will be required to find out if the implant is effective and more successful than the treatments currently used but researchers are very hopeful.

In conclusion

Malignant melanoma is the most serious type of skin cancer in humans and is currently treated surgically.  The new implant vaccine could mean an end to misery for thousands of sufferers, and could finally see the defeat of another form of fatal cancer.


Image sourceHarvard University


Alison Page

About Alison Page

Alison is a small business owner, freelance writer, author and dressage judge. She has degrees in Equine Science and Business Studies. Read her full story at

Alison Page

Top Posts | Research

Mediterranean diet

Mediterranean Dietary Lifestyle May Prevent Breast Cancer

Dr. Miguel Á. Martínez-González, MD, from the Instituto de Salud Carlos III in Madrid, and colleagues reported that breast cancer may be prevented by adopting a Mediterranean diet lifestyle that is known to be protective against cardiovascular diseases. The Mediterranean diet c ... ...

Immunological Cancer Therapy Takes Precedence

The human body is very tough. It can take a lot of abuse and still manage to function. However, just like a well-built machine, it is the internals of the human body that matter more than what is outside. So if something attacks from within, there is a chance that it may be enough to take over the ...

Sitting Linked to Increased Risk for Cancer in Women

According to a study conducted by the American Cancer Society, sitting too much can raise cancer risk in females. The study shows that women who spend 6 hours or more of their time sitting have increased cancer risk by 10% in comparison to the women who spend 3 hours of their time per day sitting.T ...

Light to Moderate Alcohol Intake Increases Cancer Risk

Dr. Edward L. Giovannucci, MD, ScD, Professor of Nutrition, Harvard T. H. Chan School of Public Health, Boston, and colleagues reported that light to moderate alcohol intake increases cancer risk. The research team urged for updated health precautions on alcohol intake. The research team explained ...

Coffee Might Lower the Recurrence Risk of Colon Cancer

Dr. Charles Fuchs, MD, MPH, from the University of Dana-Farber Cancer Institute in Boston and colleagues reported that coffee might lower the recurrence risk of colon cancer. Despite their findings, the research team warned that these findings are not evidence of causation and are only associations ...